Sei Investments »

Rapport Therapeutics shares owned by Sei Investments

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Sei Investments from 13F filings

Historical chart of Sei Investments investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Sei Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Sei Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $242k 8.2k 29.70

More positions owned by Sei Investments

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Meta Platforms Cl A (META)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core Msci Intl (IDEV)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Oracle Corporation (ORCL)

View all positions for Sei Investments

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
Sofinnova Ventures
Johnson & Johnson
Vanguard Group
BlackRock
Baker Bros. Advisors
Siren
Trv Gp Vi
Vestal Point Capital
Polar Capital Holdings

View all funds holding Rapport Therapeutics